2. Disease Areas
  3. Metabolic or Endocrine Disease
  4. Glucose Metabolism
  5. Type 2 Diabetes

Type 2 Diabetes

Type 2 diabetes is a multifactorial disorder characterized by insulin resistance and impaired glucose homeostasis, commonly associated with obesity and metabolic syndrome, which includes insulin resistance, hypertension, and hypertriglyceridemia. It can lead to serious complications affecting the eyes, kidneys, nerves, and blood vessels.

Type 2 Diabetes (1):

Cat. No. Product Name CAS No. Purity Chemical Structure
  • HY-17386
    Rosiglitazone 122320-73-4 99.94%
    Rosiglitazone (BRL 49653) is an orally active selective PPARγ agonist (EC50: 60 nM, Kd: 40 nM). Rosiglitazone is an TRPC5 activator (EC50: 30 μM) and TRPM3 inhibitor. Rosiglitazone can be used in the research of obesity and diabetes, senescence, ovarian cancer.
    Rosiglitazone